Compare OLN & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OLN | TMDX |
|---|---|---|
| Founded | 1892 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.6B |
| IPO Year | 1994 | 2019 |
| Metric | OLN | TMDX |
|---|---|---|
| Price | $19.10 | $88.58 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 9 |
| Target Price | $25.23 | ★ $148.22 |
| AVG Volume (30 Days) | ★ 3.2M | 969.9K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.92% | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | N/A | ★ 0.61 |
| Revenue | ★ $6,780,800,000.00 | $605,494,000.00 |
| Revenue This Year | $2.57 | $24.25 |
| Revenue Next Year | $3.51 | $18.75 |
| P/E Ratio | ★ N/A | $146.95 |
| Revenue Growth | 3.68 | ★ 37.13 |
| 52 Week Low | $17.73 | $60.11 |
| 52 Week High | $30.46 | $156.00 |
| Indicator | OLN | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 39.41 | 64.49 |
| Support Level | $18.54 | $66.64 |
| Resistance Level | $21.41 | $152.95 |
| Average True Range (ATR) | 0.86 | 4.31 |
| MACD | -0.07 | 1.16 |
| Stochastic Oscillator | 26.11 | 92.03 |
Olin was founded in 1892 and has been publicly listed since 1917. The company has a unique dual identity compared with some of its chemical peers: it is the world's largest chlor-alkali producer by capacity, and it owns the Winchester brand, a leading US ammunition manufacturer. Olin has three reportable segments: chlor-alkali products and vinyls (CAPV or CAP), Epoxies, and Winchester, which represent around 55%, 20%, and 25% of sales, respectively.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.